Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinics

Christopoulos, K. A., Smith, M. B., Pareek, P., Dawdani, A., Erguera, X. A., Dance, K. V., Walker, R. S., Grochowski, J., Mayorga‐Munoz, F., Hickey, M. D., Johnson, M. O., Sauceda, J., Gutierrez, J. I., Montgomery, E. T., Colasanti, J. A., Collins, L. F., McNulty, M. C., & Koester, K. A. (2024). Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long‐acting cabotegravir/rilpivirine among early adopters in three U.S. clinics. Journal of the International AIDS Society, 27(11). Portico. https://doi.org/10.1002/jia2.26394
Authors:
Katerina A Christopoulos
Mollie B Smith
Priyasha Pareek
Alicia Dawdani
Xavier A Erguera
Kaylin V Dance
Ryan S Walker
Janet Grochowski
Francis Mayorga-Munoz
Matthew D Hickey
Mallory O Johnson
John Sauceda
Jose I Gutierrez
Elizabeth T Montgomery
Jonathan A Colasanti
Lauren F Collins
Moira C McNulty
Kimberly A Koester
Affiliated Authors:
Ryan S Walker
Columbia Affiliation:
Subjects:
HIV Infections (MeSH)
Pyridones (MeSH)
Anti-HIV Agents (MeSH)
Rilpivirine (MeSH)
Qualitative Research (MeSH)
Author Keywords:
adherence
antiretroviral agents
cabotegravir
injections
rilpivirine drug combination
viral suppression
elink
Publication Type:
Article
Unique ID:
10.1002/jia2.26394
PMID:
39568168
DOI:
10.1002/jia2.26394
Journal:
Journal of the International AIDS Society
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: